Page URL:

New gene test could help to prevent strokes

10 July 2007
Appeared in BioNews 415

A new genetic test, developed by the Icelandic based company deCODE Genetics, in collaboration with academic colleagues from Iceland, Sweden, the United States and China, may help with the early identification of people with atrial fibrillation (AF), a common heart abnormality characterised by momentary heart palpitations, and believed to be the leading cause of stroke.

The results of a clinical trial of the test, published in the journal Nature Genetics last week, indicate that two 'spelling mistakes' in the genetic code, known as gene variants, significantly increased the risk AF. They found that at least one of the variants was present in one in three European descendants, and three in four Chinese descendants, studied.

'This is an important discovery with immediate clinical application', says Kari Stefansson, neuroscientist and Chief Executive of deCODE. 'With the discovery of these variants, and the availability of a test to detect them, doctors may now be able to focus monitoring on those most likely to have transient AF', he adds.

With a few exceptions, humans carry two copies of every gene, one from each parent. The researchers estimate that those who inherit a single copy of one of the gene variants from either parent have a 70 per cent or 40 per cent chance of being affected by AF, depending on which variant they carry. However those who inherit a copy from both parents may have double those risks.

The researchers carried out a genome-wide search on a group of 5,000 Icelanders with AF, to see which gene variants might be linked with the condition. After discovering the two variants in this population, they then looked for them in 18,000 people from other affected populations, in Sweden, the US and Hong Kong. This confirmed that the gene variants were a significant indicator of AF for people of both European and Han Chinese descent.

'Transient AF is difficult to detect in many patients', says Stefansson, claiming that it is 'impractical' and 'too costly' to closely monitor all patients affected by heart palpitations and stroke. The new test, he hopes, will target treatment and intensive monitoring to those who are at greatest risk.

However, in the long run the test must be evaluated in the clinic before it is known whether it actually leads to improved health, warns the UK's Public Health Genetics (PHG) Foundation, a charity aimed at promoting responsible and evidence-based biomedical science.

A gene test that predicts the risk of a stroke
The Daily Telegraph |  2 July 2007
DeCODE launches gene test for stroke risk
PHG Foundation |  5 July 2007
31 October 2011 - by Dr Louisa Petchey 
'Science is on the brink of changing your life'. It's a bold and risky opening statement, but I find my initial scepticism quelled. Whether this is due to the promise coming from the revered Professor Stephen Hawking, or because I've allowed myself to get caught up in the increasingly dramatic soundtrack is hard to say. But either way, the addition of flashy sound bites from enthusiastic scientific celebrities coupled with epic landscape shots from exotic destinations is sufficient to convinc...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.